Moleculin Biotech MBRX
NASDAQ MBRX
$0.53 -0.04 (-7.49%)
At close: Sep 29, 2026 · 4:00 PM EDT

Moleculin Biotech (MBRX) Receivables (2018 - 2023)

Updated

Moleculin Biotech (MBRX) reported Receivables of $12,000 for Q2 2023.

Analysis

Moleculin Biotech (MBRX) Receivables (2018 - 2023) Analysis & Trends

At the end of FY2022, Moleculin Biotech posted Receivables of $22,000.

  • Receivables has a four-year compound annual growth rate of -20.8% (FY2018 to FY2022).
  • By year, Receivables came in at $11,000 in FY2019 (-80.4%) and $56,000 in FY2018.
  • The Q2 2023 figure ranks as the lowest quarterly Receivables since Q1 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 19.05 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 13.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.56 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 9.64 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.68 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.23 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 5.06 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 12.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.13 Bn
10 Moleculin Biotech 3.24 Mn 3.24 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 12,000.00
Dec 31, 2022 22,000.00
Mar 31, 2020 1,000.00
Dec 31, 2019 11,000.00
Sep 30, 2019 316,000.00
Dec 31, 2018 56,000.00
API Access

Moleculin Biotech Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=MBRX&period=max&api_key=YOUR_API_KEY